Epizyme, Inc. Insider Trading for June 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for June 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.43 | 52,473 | 652,134 | 0 | 52.5 K to 0 (-100.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 12.85 | 52,472 | 674,176 | 52,473 | 104.9 K to 52.5 K (-50.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | S | 13.31 | 52,472 | 698,649 | 104,945 | 157.4 K to 104.9 K (-33.33 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 157,417 | 0 | 157,417 | 0 to 157.4 K |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 38,646 | 0 | 39,297 | 651 to 39.3 K (+5,936.41 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 767,500 | 0 | 0 | 767.5 K to 0 (-100.00 %) |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Buy | J | 0.00 | 767,500 | 0 | 767,500 | 0 to 767.5 K |
Jun 26 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Sell | J | 0.00 | 2,500,000 | 0 | 3,971,018 | 6.5 M to 4 M (-38.63 %) |
Jun 17 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Sell | S | 11.97 | 1,195 | 14,304 | 35,699 | 36.9 K to 35.7 K (-3.24 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Sell | S | 12.10 | 203 | 2,456 | 497 | 700 to 497 (-29.00 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Beaulieu Joseph | Corporate Controlle ... | Grant | A | 0.00 | 700 | 0 | 700 | 0 to 700 |
Jun 14 2019 | EPZM | Epizyme, Inc. | Agarwal Shefali | Chief Medical Offic ... | Grant | A | 0.00 | 4,000 | 0 | 36,894 | 32.9 K to 36.9 K (+12.16 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Sell | S | 12.10 | 1,185 | 14,339 | 39,032 | 40.2 K to 39 K (-2.95 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Ros Matthew | See Remarks | Grant | A | 0.00 | 4,000 | 0 | 40,217 | 36.2 K to 40.2 K (+11.04 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Sell | S | 12.10 | 2,074 | 25,095 | 84,994 | 87.1 K to 85 K (-2.38 %) |
Jun 14 2019 | EPZM | Epizyme, Inc. | Bazemore Robert B | President & CEO | Grant | A | 0.00 | 7,000 | 0 | 87,068 | 80.1 K to 87.1 K (+8.74 %) |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 12.39 | 1,891 | 23,429 | 13,979 | 12.1 K to 14 K (+15.64 %) |
Jun 07 2019 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Grant | A | 12.39 | 1,024 | 12,687 | 7,471 | 6.4 K to 7.5 K (+15.88 %) |
Jun 07 2019 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | Allen Andrew R | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | Conroy Kevin T | Director | Grant | A | 12.39 | 897 | 11,114 | 3,775 | 2.9 K to 3.8 K (+31.17 %) |
Jun 07 2019 | EPZM | Epizyme, Inc. | Giordano Michael F | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
Jun 07 2019 | EPZM | Epizyme, Inc. | POPS RICHARD F | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 |